The decision follows from a liquidity shortfall in Nectarine Health and is deemed necessary to give Nectarine Health the time required to negotiate a longer-term financial solution and implement certain operational changes.  It is believed that a corporate restructuring will both improve Nectarine Health's business prospects and will also have a significant positive impact on Brighter's liquidity and thus enable a stronger focus on the core business.

During 2021, Nectarine Health has transitioned from a product development stage to its current phase involving parallel commercialization. This involves, among other things, end-user tests. and in 2022 Nectarine Health signed an agreement with JRW Services, an independent Right at Home franchisee in the United States. The company also has in March 2022 entered into an agreement with Dynamark Monitoring Inc. which provides call centers for monitoring of personal emergency services in the United States. This integration will allow users in the United States to connect to a call center in the event of an emergency alert.

"I see great opportunities for Nectarine Health. In the US, the company has received all regulatory approvals linked to electronic communications (FCC) for all three devices that make up Nectarine Health™ at Home. The system has also been registered with the U.S. Food and Drug Administration (FDA). The Nectarine Health™ at Home app, to be used by the end user and caregivers, family members and healthcare providers has been approved by both Apple and Google, which means it is available for download in both AppStore and PlayStore. I hope that Nectarine Health, through a corporate restructuring,  will have the opportunity to build on that potential," says Christer Trägårdh, Chairman of the Board of Nectarine Health and Brighter AB

The district court will more or less immediately examine the application for company restructuring. Therefore, Nectarine Health expects a decision shortly.

For more information, please contact:
Investor Relations
IR@brighter.se

Certified Adviser
Brighter's Certified Adviser is Mangold Fondkommission AB,

About Brighter
Brighter is a health-tech company from Sweden with a vision of a world where managing chronic diseases is no longer a struggle. We believe a data-centric approach is key to providing smarter care for chronic conditions. Our daily-care solutions are designed with a vision to facilitate the flow of real-life treatment data between chronic-disease patients, their loved ones and their care providers - aiming to improve quality of life, easing the burden on healthcare systems, and opening new opportunities for data-driven research. Brighter's quality management system is ISO13485 certified. In 2019 the Company won the Swecare Rising Stars Award. The Company's shares are listed on Nasdaq First North Growth Market/BRIG. For more information, please visit our website at www.brighter.se.